Optimizing ALS Clinical Trials to Incorporate the Evolving Standard of Care & Standardize Trial Design
Time: 1:00 pm
day: Pre-Conference Day Track B
With an increasing number of ALS therapies entering human trials – understanding the best strategy for clinical trial design is crucial. Attend this workshop to learn the optimal clinical trial design in light of recent market approvals, differing trial duration and participant selection strategies.
Workshop highlights include:
• Understanding how to measure novel candidate efficacy magnitude against an evolving standard of care placebo
• 6-18 months: what is the ideal trial duration to bridge the gap between efficacy measurements and participant burden?
• Defining inclusion and exclusion